Public-registry site landscape for NCT04983407, a Pancreatic Adenocarcinoma study sponsored by Aravive, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04983407 (registry record) |
| Sponsor | Aravive, Inc. |
| Condition(s) | Pancreatic Adenocarcinoma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 17 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04983407 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →